Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEPH-ROSIS Pilot Trial
NCT06000748Phase 3Terminated
- Sponsor
- University of California, San Francisco
- Start
- Feb 2024
- Primary completion
- Jul 2024
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in acute kidney injury (AKI) and Cirrhosis (2 arms), sponsored by University of California, San Francisco. Primary endpoint: Mean Arterial Pressure at 14 days. Started Feb 2024; status: terminated.
02
Conditions
acute kidney injury (AKI)Cirrhosis
Beyond the preview
Go deeper on NCT06000748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06000748.